The largest database of trusted experimental protocols

Prl cmv renilla luciferase reporter

Manufactured by Promega

The PRL-CMV Renilla luciferase reporter is a plasmid vector that expresses the Renilla luciferase gene under the control of the CMV promoter. The Renilla luciferase enzyme catalyzes a bioluminescent reaction that can be used to quantify gene expression.

Automatically generated - may contain errors

3 protocols using prl cmv renilla luciferase reporter

1

Luciferase Reporter Assay for miRNA Target Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
TCTTAAACATTGTTTTGTAGTGTATATTACTTGTCCATTCCTTTAAGGGGAGCTTTAAACACTCTTTTGTAGATTACTTTTGGGGGATATATTTTGAGAATGATGAAACGGAATAAAATTGTAAAAAATTAATTGTAGTTTTAA.
Seventy-thousand cells were seeded in 24-well plates and co-transfected with 100 nM of mirVana miRNA mimic, negative control #1 (Cat# 4464058), or miR-484 mimic (Cat# 4464066, Assay ID MC10379) from Thermo, 100 ng of luciferase reporter pLenti-UTR-Luc PSMG1 WT or pLenti-UTR-Luc PSMG1 MUT, and 4 ng of pRL-CMV Renilla luciferase reporter (Cat# E2261) from Promega (Madison, WI), using TransIT-X2 (Cat# 6004) from Mirus (Madison, WI). Cells were cultured for another 48 h and washed once in PBS. Using a Luc-Pair Duo-Luciferase HS Assay Kit (Cat# LF004) from GeneCopoeia (Rockville, MD), cells were then lysed, loaded onto white 96-wells in quadruplicates, and their luciferase/Renilla ratios were measured using a FLUOstar Omega microplate reader from BMG Labtech. The experiment was repeated for n = 4.
+ Open protocol
+ Expand
2

Cloning TERT Promoter Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 528 bp and 1051 bp DNA fragment upstream of TERT TSS were amplified from A549 cells DNA using primers listed in Table 7. The DNA fragments were inserted into the pGLbasic. Two analogous 600 bp DNA fragments encompassing the rs2853677 site were amplified from A549 cells and the T or the C-allele were subsequently inserted in forward or inverted orientation into upstream of the TERT promoter. Plasmids were cotransfected into HEK293 cells using Lipofectamine 2000 (Invitrogen) with pRL-CMV Renilla luciferase reporter, which was used for normalization (Promega).
+ Open protocol
+ Expand
3

Dual-Luciferase Assay for miR-491 Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 293T cells were seeded in 96-well plates and co-transfected with either pRL-CMV Renilla luciferase reporter, firefly luciferase reporter, or miR-491 mimic. The luciferase activities of Renilla and firefly reporter vectors were quantified using a dual-luciferase reporter assay according to the manufacturer's protocol (Promega Corporation) after 48 h of incubation. The 3′ untranslated regions (UTRs) were taken from FOXP4, and the binding site of circ-0000212 with miR-491 was taken from circ-0000212. The sequences containing the miR-491-binding sites or point mutations in the binding sites were inserted between SpeI and HindIII sites in the firefly luciferase reporter vectors, in order to generate wild-type and mutant luciferase reporter vectors, respectively. These sequences were all obtained from Shanghai GenePharma Co., Ltd. The pRL-CMV Renilla luciferase reporter was purchased from Promega Corporation. Lipofectamine 2000 was used to perform transfection according to the manufacturer's protocol. Briefly, the 293T cells were seeded 24 h prior to transfection at 50–60% confluence. The cells were transfected once they reached ~70% confluence with 50 ng plasmids, and 20 nM miRNA mimics or miRNA inhibitor, according to the manufacturer's protocol. Luciferase activity was measured 48 h post-transfection and Renilla luciferase activity was used as a control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!